When MAGE meets RING: Insights into biological functions of MAGE proteins

Protein and Cell

Volumn 2, Issue 1, 2011, Pages 7-12

  Feng, Yue ^a   Gao, Jinlan ^a   Yang, Maojun ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

cancer testis antigen; MAGE; RING; TRIM28; ubiquitin ligase

Indexed keywords

MELANOMA ANTIGEN; RING FINGER PROTEIN; UBIQUITIN PROTEIN LIGASE E3;

COMPLEX FORMATION; CONFORMATIONAL TRANSITION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; MELANOMA; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RING FINGER MOTIF;

EID: 79953214941     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-011-1002-9     Document Type: Review

References (44)

1. Barker, P. A., and Salehi, A. (2002). The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosci Res 67, 705-712.
2. Bolli, M., Kocher, T., Adamina, M., Guller, U., Dalquen, P., Haas, P., Mirlacher, M., Gambazzi, F., Harder, F., Heberer, M., et al. (2002). Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma. Ann Surg 236, 785-793, discussion 793.
3. Borden, K. L. (2000). RING domains: master builders of molecular scaffolds? J Mol Biol 295, 1103-1112.
4. Brasseur, F., Rimoldi, D., Liénard, D., Lethé, B., Carrel, S., Arienti, F., Suter, L., Vanwijck, R., Bourlond, A., Humblet, Y., et al. (1995). Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer 63, 375-380.
5. Brichard, V. G., and Lejeune, D. (2007). GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development. Vaccine 25, B61-B71.
6. Chomez, P., De Backer, O., Bertrand, M., De Plaen, E., Boon, T., and Lucas, S. (2001). An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 61, 5544-5551.
7. Cilensek, Z. M., Yehiely, F., Kular, R. K., and Deiss, L. P. (2002). A member of the GAGE family of tumor antigens is an anti-apoptotic gene that confers resistance to Fas/CD95/APO-1, Interferongamma, taxol and gamma-irradiation. Cancer Biol Ther 1, 380-387.
8. Colaluca, I. N., Tosoni, D., Nuciforo, P., Senic-Matuglia, F., Galimberti, V., Viale, G., Pece, S., and Di Fiore, P. P. (2008). NUMB controls p53 tumour suppressor activity. Nature 451, 76-80.
9. De Smet, C., Courtois, S. J., Faraoni, I., Lurquin, C., Szikora, J. P., De Backer, O., and Boon, T. (1995). Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene. Immunogenetics 42, 282-290.
10. Di Certo, M. G., Corbi, N., Bruno, T., Iezzi, S., De Nicola, F., Desantis, A., Ciotti, M. T., Mattei, E., Floridi, A., Fanciulli, M., et al. (2007). NRAGE associates with the anti-apoptotic factor Che-1 and regulates its degradation to induce cell death. J Cell Sci 120, 1852-1858.
11. Doyle, J. M., Gao, J., Wang, J., Yang, M., and Potts, P. R. (2010). MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell 39, 963-974.
12. Duan, Z., Duan, Y., Lamendola, D. E., Yusuf, R. Z., Naeem, R., Penson, R. T., and Seiden, M. V. (2003). Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines. Clin Cancer Res 9, 2778-2785.
13. Espantman, K. C., and O'shea, C. C. (2010). aMAGEing new players enter the RING to promote ubiquitylation. Mol Cell 39, 835-837.
14. Goldman, B., and DeFrancesco, L. (2009). The cancer vaccine roller coaster. Nat Biotechnol 27, 129-139.
15. Jackson, P. K., Eldridge, A. G., Freed, E., Furstenthal, L., Hsu, J. Y., Kaiser, B. K., and Reimann, J. D. (2000). The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends Cell Biol 10, 429-439.
16. Jordan, B. W., Dinev, D., LeMellay, V., Troppmair, J., Gotz, R., Wixler, L., Sendtner, M., Ludwig, S., and Rapp, U. R. (2001). Neurotrophin receptor-interacting mage homologue is an inducible inhibitor of apoptosis protein-interacting protein that augments cell death. J Biol Chem 276, 39985-39989.
17. Kendall, S. E., Battelli, C., Irwin, S., Mitchell, J. G., Glackin, C. A., and Verdi, J. M. (2005). NRAGE mediates p38 activation and neural progenitor apoptosis via the bone morphogenetic protein signaling cascade. Mol Cell Biol 25, 7711-7724.
18. Liu, Y., Zhu, Q., and Zhu, N. (2008). Recent duplication and positive selection of the GAGE gene family. Genetica 133, 31-35.
19. López-Sánchez, N., González-Fernández, Z., Niinobe, M., Yoshikawa, K., and Frade, J. M. (2007). Single mage gene in the chicken genome encodes CMage, a protein with functional similarities to mammalian type II Mage proteins. Physiol Genomics 30, 156-171.
20. Lorick, K. L., Jensen, J. P., Fang, S., Ong, A. M., Hatakeyama, S., and Weissman, A. M. (1999). RING fingers mediate ubiquitinconjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci U S A 96, 11364-11369.
21. Meroni, G., and Diez-Roux, G. (2005). TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 27, 1147-1157.
22. Miranda, E. I. (2010). MAGE, biological functions and potential clinical applications. Leuk Res 34, 1121-1122.
23. Moon, H. E., Ahn, M. Y., Park, J. A., Min, K. J., Kwon, Y. W., and Kim, K. W. (2005). Negative regulation of hypoxia inducible factor-lalpha by necdin. FEBS Lett 579, 3797-3801.
24. Nasmyth, K., and Haering, C. H. (2005). The structure and function of SMC and kleisin complexes. Annu Rev Biochem 74, 595-648.
25. Nie, J., McGill, M. A., Dermer, M., Dho, S. E., Wolting, C. D., and McGlade, C. J. (2002). LNX functions as a RING type E3 ubiquitin ligase that targets the cell fate determinant Numb for ubiquitin-dependent degradation. EMBO J 21, 93-102.
26. Ohman Forslund, K., and Nordqvist, K. (2001). The melanoma antigen genes-any clues to their functions in normal tissues? Exp Cell Res 265, 185-194.
27. Park, J. H., Kong, G. H., and Lee, S. W. (2002). hMAGE-A1 over-expression reduces TNF-alpha cytotoxicity in ME-180 cells. Mol Cells 14, 122-129.
28. Patard, J. J., Brasseur, F., Gil-Diez, S., Radvanyi, F., Marchand, M., François, P., Abi-Aad, A., van Cangh, P., Abbou, C. C., Chopin, D., et al. (1995). Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int J Cancer 64, 60-64.
29. Pawson, T., and Nash, P. (2003). Assembly of cell regulatory systems through protein interaction domains. Science 300, 445-452.
30. Pebernard, S., McDonald, W. H., Pavlova, Y., Yates, J. R. 3rd, and Boddy, M. N. (2004). Nse1, Nse2, and a novel subunit of the Smc5-Smc6 complex, Nse3, play a crucial role in meiosis. Mol Biol Cell 15, 4866-4876.
31. Pebernard, S., Perry, J. J., Tainer, J. A., and Boddy, M. N. (2008). Nse1 RING-like domain supports functions of the Smc5-Smc6 holocomplex in genome stability. Mol Biol Cell 19, 4099-4109.
32. Potts, P. R. (2009). The Yin and Yang of the MMS21-SMC5/6 SUMO ligase complex in homologous recombination. DNA Repair (Amst) 8, 499-506.
33. Rual, J. F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., Berriz, G. F., Gibbons, F. D., Dreze, M., Ayivi-Guedehoussou, N., et al. (2005). Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173-1178.
34. Sasaki, A., Masuda, Y., Iwai, K., Ikeda, K., and Watanabe, K. (2002). A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msxinteracting MAGE/Necdin family protein, Dlxin-1. J Biol Chem 277, 22541-22546.
35. Scanlan, M. J., Gure, A. O., Jungbluth, A. A., Old, L. J., and Chen, Y. T. (2002). Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 188, 22-32.
36. Scanlan, M. J., Simpson, A. J., and Old, L. J. (2004). The cancer/testis genes: review, standardization, and commentary. Cancer Immun 4, 1.
37. Sergeant, J., Taylor, E., Palecek, J., Fousteri, M., Andrews, E. A., Sweeney, S., Shinagawa, H., Watts, F. Z., and Lehmann, A. R. (2005). Composition and architecture of the Schizosaccharomyces pombe Rad18 (Smc5-6) complex. Mol Cell Biol 25, 172-184.
38. Simpson, A. J., Caballero, O. L., Jungbluth, A., Chen, Y. T., and Old, L. J. (2005). Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 5, 615-625.
39. Taylor, E. M., Copsey, A. C., Hudson, J. J., Vidot, S., and Lehmann, A. R. (2008). Identification of the proteins, including MAGEG1, that make up the human SMC5-6 protein complex. Mol Cell Biol 28, 1197-1206.
40. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., van den Eynde, B., Knuth, A., and Boon, T. (1991). A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643-1647.
41. Varfolomeev, E., and Vucic, D. (2008). (Un)expected roles of c-IAPs in apoptotic and NFkappaB signaling pathways. Cell Cycle 7, 1511-1521.
42. Wang, C., Ivanov, A., Chen, L., Fredericks, W. J., Seto, E., Rauscher, F. J. 3rd, and Chen, J. (2005). MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J 24, 3279-3290.
43. Yang, B., O'Herrin, S. M., Wu, J., Reagan-Shaw, S., Ma, Y., Bhat, K. M., Gravekamp, C., Setaluri, V., Peters, N., Hoffmann, F. M., et al. (2007). MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res 67, 9954-9962.
44. Zheng, N., Schulman, B. A., Song, L., Miller, J. J., Jeffrey, P. D., Wang, P., Chu, C., Koepp, D. M., Elledge, S. J., Pagano, M., et al. (2002). Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416, 703-709.